早期发病后辐射神经病变患者的临床,神经生理学和病理学特征
Michael Skolka1, Shahar Shelly1, Marcus V Pinto1
1From the Department of Neurology (M.S., M.V.P., D.D., T.O., J.H.U., A.S., N.P.S., P.J.B.D., C.E.R., C.J.K.), Mayo Clinic, Rochester, MN; Department of Neurology (S.S.), Rambam Health Care Clinic, Haifa, Israel; Department of Neurosurgery (R.J.S.); and Department of Laboratory Medicine and Pathology (C.J.K.), Mayo Clinic, Rochester, MN.
Neurology
|July 3, 2023
概括
早期发病的辐射诱导神经病变通常呈现为痛苦的,单相状况,持久的缺陷. 这些神经病变可能会对类固醇产生反应,并表明炎症性,缺血性原因.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 放射治疗可以导致神经病变,这是一个已知的并发症.
- 早期发病的辐射诱导神经病变 (RIND) 与慢性形式不同.
- 了解RIND对于患者的管理和预后至关重要.
研究的目的:
- 为了研究早期RIND的特征.
- 在早期发病的RIND患者中审查神经病程,对类固醇的反应和神经活检结果.
主要方法:
- 在辐射后6个月内诊断出RIND的患者的回顾性评估.
- 纳入标准:在辐射场内的电诊断证实的神经病变.
- 神经学过程,治疗反应和神经活检结果的分析.
主要成果:
- 确定了28名早期RIND患者,平均辐射剂量为4659cGy.
- 常见的症状包括神经病痛和软弱;典型的局部化是腰部 sacral plexopathies 和 radiculopathies.
- 神经活检显示出炎症性缺血过程;接受类固醇治疗的9名患者中有8名症状有所改善,但没有人完全康复.
结论:
- 早期发病的RIND通常呈现为痛苦的单相神经病变,残留缺陷.
- 在某些情况下,类固醇治疗可能会缓解症状.
- 研究结果表明,早期发病RIND的潜在缺血和炎症病原体.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Parkinson's Disease: Overview
606
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606
Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527
Local Anesthetics: Differential Sensitivity of Nerve Fibers
876
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
876


